PMHNP Scope of Practice for General Psychiatry in Florida

If you’re a psychiatrist or psychiatric nurse practitioner navigating the world of telepsychiatry, you’ve probably asked yourself some version of this question: ‘Can I still prescribe ADHD medications via video visits? What about starting a new patient on anxiety meds remotely? Are the COVID rules over, or are they extended?’

You’re not alone. The regulatory landscape for prescribing controlled substances via telehealth has been shifting constantly since March 2020, and it’s about to shift again. Here’s what you need to know right now — and what’s coming next.

The Bottom Line (As of Early 2026)

Yes, you can prescribe Schedule II–V controlled substances via telehealth to most patients without requiring an in-person visit first — but this is under a temporary federal extension that runs through December 31, 2026. After that, new permanent DEA rules will likely take effect, changing how we practice telepsychiatry with controlled medications.

The DEA and HHS announced in January 2026 that they’re extending the COVID-era telehealth flexibilities for a fourth time while finalizing permanent regulations. This means psychiatrists and PMHNPs can continue prescribing stimulants (like Adderall, Ritalin), benzodiazepines (Xanax, Klonopin), and other controlled meds through video consultations — no initial in-person exam required — through the end of 2026.

But — and this is critical — you must also comply with state telehealth laws, which can be more restrictive than federal rules. Some states like Florida have explicit carve-outs for psychiatric prescribing, while others like Texas impose strict limits on what nurse practitioners can prescribe. And all states require you to check their prescription monitoring databases and follow standard-of-care protocols.

Let’s break down what you’re allowed to do now, what’s changing, and how to stay compliant.

Free consultations available with select providers only.

Grow your practice on Klarity

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

Start seeing patients

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

What the Current Federal Rules Allow (Through December 2026)

Under the Ryan Haight Act (passed in 2008), prescribing controlled substances online normally requires at least one in-person medical evaluation. The law was designed to combat ‘pill mills’ that would prescribe opioids after just an online questionnaire.

When COVID hit, the DEA invoked emergency authority to waive that in-person requirement, recognizing that mental health patients needed access to care during lockdowns. That waiver has been extended multiple times, most recently through the end of 2026.

What you can do right now:

• New patients never seen in person: You can prescribe Schedule II–V controlled substances via telehealth (two-way audio-video) after conducting an appropriate evaluation. This includes stimulants for ADHD, benzodiazepines for anxiety disorders, and buprenorphine for opioid use disorder.

• Established patients: If you’ve ever seen a patient in person (or another provider in your practice has), there’s no federal restriction on prescribing controlled substances via telehealth for ongoing care. You’re just maintaining continuity of the existing patient-provider relationship.

• Documentation requirements: You must conduct a proper psychiatric evaluation (history, mental status exam, diagnostic assessment) and document it as you would for an in-person visit. The standard of care doesn’t change just because it’s video instead of face-to-face.

What you cannot do (or should avoid):

• Telephone-only for most controlled substances: Audio-only consultations generally don’t meet the DEA’s telemedicine standard, except for specific cases like buprenorphine for OUD (where the DEA has explicitly allowed audio-only during the extension). For stimulants or benzodiazepines, use interactive video.

• Prescribing without an adequate evaluation: You can’t just have patients fill out a questionnaire and send them a script. State medical boards have disciplined providers who prescribed controlled substances after only online forms with no real-time consultation.

• Ignoring state-specific restrictions: Even though federal law currently allows telehealth prescribing, your state might impose additional requirements or outright bans on certain practices.

What’s Coming: The DEA’s Proposed Permanent Rules

In January 2025, the DEA announced three new proposed rules to replace the temporary COVID extensions. These rules are currently open for public comment and won’t be finalized until sometime in 2026, but they give us a roadmap for the future of telepsychiatry prescribing.

1. Buprenorphine Expansion (Opioid Use Disorder Treatment)

The DEA proposes allowing clinicians to prescribe buprenorphine for OUD via telehealth (including audio-only) for up to 6 months without an in-person visit. After 6 months, the patient would need at least one in-person evaluation before continuing treatment.

This is significant because it formalizes what many addiction psychiatrists have been doing during COVID. If you’re treating patients with opioid addiction, you’d have a clear legal pathway to initiate and continue buprenorphine via telemedicine, with only an eventual in-person touchpoint required.

Why this matters for you: If you treat substance use disorders, this rule would give you legal certainty to continue telehealth MAT (medication-assisted treatment) indefinitely, as long as you see patients in person at least once every 6 months.

2. Special Telemedicine Registration for Schedule II Prescribing

Here’s the big one for general psychiatry: The DEA proposes creating a ‘Special Telemedicine Registration’ that would allow qualified providers to prescribe Schedule II controlled substances to new patients via telehealth without any in-person exam requirement.

For Schedule III–V substances (like some sleep meds, low-dose stimulants), any DEA-registered provider could obtain this special registration. But for Schedule II substances (Adderall, Ritalin, Vyvanse, immediate-release Dexedrine), the DEA is initially limiting eligibility to certain specialties:

• Board-certified psychiatrists
• Hospice and palliative care physicians
• Long-term care facility physicians
• Pediatricians (for a narrow formulary)

What this means: If you’re a board-certified psychiatrist, you’d be able to apply for this special registration and continue prescribing ADHD medications via telehealth indefinitely — even to brand-new patients who’ve never been seen in person by anyone. The DEA is essentially recognizing that mental health providers can safely manage these medications in a telehealth-only model.

PMHNPs would likely be eligible for the special registration for Schedule III–V prescribing, but probably not Schedule II unless the DEA expands eligibility after public feedback.

Additional requirements under the proposed rule:

• Telehealth platforms themselves would need to register with the DEA and implement safeguards against overprescribing
• A national Prescription Drug Monitoring Program (PDMP) would be created to track controlled prescriptions across states
• Providers with the special registration would need to report their telehealth prescribing activity (likely annually)
• The DEA is considering whether the special registration would allow prescribing only within your home state or across state lines (still under discussion)

3. VA Continuity of Care Rule

This is specific to the Veterans Administration system but illustrates a broader principle: If a patient has had an in-person exam with any clinician in the VA system, any VA telehealth provider (even in a different state) can prescribe controlled substances to that patient via telemedicine.

The principle here — treating an entire healthcare system as satisfying the in-person requirement — could eventually extend to large healthcare networks outside the VA, but that’s speculative for now.

State-by-State Variations: Where It Gets Complicated

Even with federal permission to prescribe via telehealth, you must follow your state’s laws. Some states have been more restrictive than federal rules, while others have been more permissive (at least for mental health).

California: Telehealth-Friendly with PDMP Requirements

California doesn’t impose its own in-person exam requirement for telehealth prescribing. As long as you conduct an evaluation that meets the standard of care (which can be done via video), you can prescribe controlled substances.

Key compliance points:

• PDMP checks: You must check California’s CURES database before prescribing any Schedule II–IV controlled substance for the first time, and then every 4 months for ongoing treatment
• E-prescribing: All prescriptions (not just controlled substances) must be sent electronically as of January 2022
• NP independence: Psychiatric NPs in California are transitioning to full practice authority. As of 2023, experienced PMHNPs (3+ years supervised practice) can work without physician oversight in group settings. By 2026, they’ll be able to open independent practices. This makes California attractive for telehealth platforms that want to use NPs.

Texas: Physician-Friendly, NP-Restrictive

Texas recognizes telehealth relationships and doesn’t require an in-person visit for mental health prescribing by physicians. But there are significant restrictions on nurse practitioners.

Key points:

• NP limitations: Texas NPs and PAs cannot prescribe Schedule II controlled substances outside of hospital or hospice settings. This means a PMHNP in Texas cannot prescribe Adderall for outpatient ADHD treatment — period. Those patients must be seen by a physician (MD/DO).
• PDMP requirements: Prescribers must check the Texas PMP before prescribing opioids, benzodiazepines, barbiturates, or carisoprodol
• Chronic pain ban: Texas prohibits prescribing controlled substances via telemedicine for chronic pain management unless the patient has had an in-person evaluation (this affects pain management more than psychiatry, but be aware if treating patients with co-morbid chronic pain)

Practical implication: If you’re building a telepsychiatry practice serving Texas patients, you’ll need MDs to handle any Schedule II prescribing. Many platforms pair psychiatrists with PMHNPs so the psychiatrist can write stimulant prescriptions when needed.

Florida: Psychiatric Carve-Out with Out-of-State Registration

Florida has one of the most detailed telehealth laws in the country. It explicitly prohibits prescribing Schedule II controlled substances via telehealth — except for four specific situations:

1. Psychiatric disorder treatment
2. Inpatient hospital care
3. Hospice care
4. Nursing home resident care

What this means: A Florida-licensed psychiatrist (or an out-of-state telehealth-registered provider) can prescribe Adderall via video visit for ADHD because it’s treating a psychiatric disorder. They cannot prescribe the same medication for, say, chronic fatigue or off-label weight loss via telehealth.

Florida also allows out-of-state providers to register as ‘Florida Telehealth Providers’ without obtaining a full Florida license, which can be helpful for multi-state practices. However, that registration doesn’t change the Schedule II prescribing rules.

Key requirements:

• PDMP checks: Must consult Florida’s E-FORCSE database before prescribing any controlled substance
• NP supervision: Psychiatric NPs in Florida require a supervising physician and collaborative agreement (unlike some other specialties that can practice independently)
• Documentation: Document the psychiatric indication for any Schedule II prescription to show it falls under the allowed categories

New York: Strict PDMP, Flexible NP Rules

New York doesn’t require an in-person visit before telehealth prescribing and has been supportive of tele-mental health expansion.

Key points:

• PDMP mandate: New York’s I-STOP law requires checking the state Prescription Monitoring Program before prescribing any Schedule II, III, or IV controlled substance — every single time
• E-prescribing: All prescriptions (controlled and non-controlled) must be electronic since 2016
• NP independence: Experienced PMHNPs (>3,600 practice hours) can practice fully independently without a collaborative agreement. This makes NY attractive for NP-led telehealth services

Pennsylvania: No Telehealth Statute, But Allowed

Pennsylvania doesn’t have a comprehensive telehealth law yet, but the state medical board allows telemedicine as long as it meets the standard of care. There’s no state-level prohibition on prescribing controlled substances via telehealth.

Key requirements:

• PDMP checks: Required before prescribing opioids or benzodiazepines (and recommended for all controlled substances)
• NP restrictions: PMHNPs need collaborative agreements with at least two physicians for prescriptive authority, and they can only prescribe Schedule II for 30 days at a time before the patient must see a physician

Illinois: Full Practice NPs with Consultation Requirements

Illinois allows full practice authority for NPs who meet experience and training requirements, but with a twist: Even independent NPs must have a physician consultation arrangement to prescribe benzodiazepines or Schedule II opioids, limited to 30-day supplies.

Key points:

• PDMP: Mandatory check before prescribing opioids
• E-prescribing: Required for all controlled substances as of 2023
• NP limitation: The ‘consultation relationship’ requirement for benzos and Schedule II meds means even independent PMHNPs need a physician partner for certain prescriptions

Compliance Best Practices: How to Prescribe Safely and Legally via Telehealth

Regardless of your state, here’s what every telepsychiatry provider should be doing:

1. Conduct a Real Evaluation

Don’t prescribe based on questionnaires alone. Conduct a live video consultation that includes:

• Detailed psychiatric history
• Mental status examination
• Review of symptoms and diagnostic criteria
• Discussion of treatment options and risks
• Documentation of medical necessity for controlled substances

State medical boards are watching for providers who prescribe after minimal interaction. In Washington state, a psychiatrist was disciplined in 2022 for prescribing controlled substances after patients filled out online forms with no live consultation.

2. Check the PDMP Every Time

Nearly every state now requires checking the prescription drug monitoring program before prescribing controlled substances. Make it part of your standard workflow:

• Check before prescribing to a new patient
• Check periodically for established patients (every 3–4 months for ongoing controlled substance prescriptions)
• Document in your note that you reviewed the PDMP and what you found

Some states require specific documentation (like California’s CURES mandate), so know your state’s rules.

3. Use E-Prescribing

Most states now require electronic prescribing for controlled substances. Use a DEA-compliant e-prescribing system with two-factor authentication. This is also just more secure and efficient than paper scripts or phone-in prescriptions.

4. Obtain Proper Licensure

You must be licensed in every state where your patients are physically located during the consultation. If you’re treating patients across state lines, either:

• Get licensed in each state (time-consuming but required)
• Use the Interstate Medical Licensure Compact if your state is a member (makes multi-state licensing faster)
• For Florida, consider the out-of-state telehealth registration option

Don’t rely on temporary COVID-era allowances that let out-of-state providers practice across state lines — those have mostly expired.

5. Document, Document, Document

Your telehealth notes should be as thorough as your in-person notes. Document:

• How you established the patient-provider relationship
• Your evaluation findings and diagnosis
• Medical necessity for controlled substances (especially important in states like Florida)
• Patient education about risks and benefits
• PDMP findings
• Your clinical reasoning for prescribing decisions

If the DEA or your state board ever questions your prescribing, your documentation is your defense.

6. Maintain Standard of Care

Telehealth doesn’t mean lower standards. If you wouldn’t prescribe a medication after a 10-minute in-person visit, don’t do it after a 10-minute video visit either.

For stimulants, this typically means:

• Confirming ADHD diagnosis (not just patient self-report)
• Ruling out substance use disorders or diversion risk
• Considering non-controlled alternatives
• Scheduling appropriate follow-ups
• Monitoring for misuse or adverse effects

For benzodiazepines and other anxiety medications:

• Document that you’ve tried or discussed non-controlled options
• Assess for substance use history
• Use lowest effective dose and consider time-limited treatment
• Monitor for dependence

The Economics of Telepsychiatry: Why Platforms Like Klarity Make Sense

Here’s the reality of building a telepsychiatry practice on your own: patient acquisition is expensive and time-consuming.

DIY marketing costs add up fast:

• Google Ads: Mental health keywords cost $15–40+ per click. Most clicks don’t convert to booked appointments. Realistically, you’re looking at $200–400+ cost per booked patient after accounting for click costs, conversion rates, and no-shows
• SEO: Takes 6–12 months of consistent investment (blog content, technical optimization, link building) before you see meaningful patient flow. Most solo providers don’t have the expertise or patience to do this effectively
• Directory listings: Psychology Today and Zocdoc charge monthly subscription fees, and you compete with hundreds of other providers on the same page. Zocdoc charges $35–100+ per booking on top of subscription costs
• Agency/consultant fees: If you hire help with marketing, expect $2,000–5,000/month minimum, with no guarantee of results

Hidden costs people forget:

• Staff time to handle and qualify leads
• No-show rates from cold leads (often 30–40% for new patients)
• Ad spend testing and optimization
• Failed campaigns that don’t convert
• Months of investment before seeing ROI

For most providers — especially those starting out or trying to scale — this gamble on marketing channels is too risky and expensive.

The platform model makes economic sense:

Platforms like Klarity Health use a pay-per-appointment model (similar to Zocdoc) where you pay a standard listing fee per new patient lead. The key advantages:

• No upfront marketing spend: You’re not gambling $3,000/month on ads that might not work
• Pre-qualified patients: Patients are already matched to your specialty and availability
• No wasted ad spend: You only pay when a qualified patient actually books with you
• Built-in infrastructure: Telehealth platform, scheduling, documentation — no separate costs
• Both insurance and cash-pay: Multiple patient sources without managing multiple channels
• You control your schedule: Only pay when you see patients, not monthly whether you get patients or not

This is guaranteed ROI vs. gambling on marketing.

Instead of spending $3,000–5,000/month on marketing with uncertain results, you pay only when a qualified patient shows up. For providers who want to focus on clinical work rather than becoming marketing experts, this model removes the entire risk of patient acquisition.

DIY marketing can eventually be cost-effective if you have the budget, expertise, and patience to invest for 6–12 months. But for most psychiatrists and PMHNPs — especially those starting out, scaling to full-time, or working locum — platforms that handle patient acquisition remove the guesswork entirely.

What to Do Now: Planning for 2026 and Beyond

If you’re currently practicing telepsychiatry:

1. Stay compliant with current rules through December 2026 (use video, check PDMPs, document thoroughly)
2. Watch for the DEA’s final rules — they’ll likely be published in mid-to-late 2026, with an implementation period
3. Consider applying for the special telemedicine registration if you’re a board-certified psychiatrist and want to continue prescribing Schedule II meds via telehealth indefinitely
4. Verify your state licenses and make sure you’re licensed in every state where you see patients

If you’re thinking about starting or expanding telepsychiatry:

1. Focus on states with favorable rules — California, New York, and Illinois offer more flexibility, especially for NPs
2. Understand your scope limitations — if you’re a PMHNP, know which states require physician collaboration and which allow independence
3. Plan for multi-state licensing if you want to maximize patient volume — use the Interstate Medical Licensure Compact if available
4. Consider joining a platform that handles patient acquisition, credentialing, and compliance infrastructure instead of building from scratch

If you’re considering joining Klarity Health:

We handle the regulatory complexity and patient acquisition so you can focus on clinical care. We credential providers in multiple states, provide patients who are already matched to your specialty, and handle all the administrative overhead of telehealth practice. You see patients, get paid per appointment, and don’t worry about marketing budgets or whether you’ll have enough patients this month.

The Bottom Line

Telepsychiatry prescribing of controlled substances is currently allowed under federal law through the end of 2026, with permanent rules expected to formalize this practice (with some additional requirements). State laws add complexity — some states have explicit carve-outs for psychiatric prescribing, while others restrict nurse practitioners or require additional documentation.

The key to staying compliant is knowing both federal DEA rules and your state’s specific requirements. Check PDMPs, document thoroughly, use video consultations for new patients and controlled substances, and maintain the standard of care you’d use in person.

And if navigating all these regulations while also marketing your practice sounds overwhelming, that’s exactly why platforms like Klarity exist — to handle the complexity so you can focus on treating patients.

Ready to explore telepsychiatry without the headaches of patient acquisition and multi-state compliance? Learn more about joining Klarity’s provider network and start seeing patients on your terms.

Frequently Asked Questions

Can I prescribe Adderall to a new patient I’ve never met in person via telehealth?

Yes, under current federal rules (extended through December 31, 2026). You must conduct a proper video evaluation and follow your state’s telehealth prescribing laws. Some states have additional requirements beyond federal law.

What happens after the federal extension expires in December 2026?

The DEA is expected to finalize permanent rules that will likely allow continued telehealth prescribing of controlled substances, but with new requirements like a special telemedicine registration for Schedule II prescriptions. Board-certified psychiatrists will be eligible for this special registration.

Do I need to see patients in person at all for telehealth prescribing?

Not under current federal rules through 2026. The proposed permanent rules for buprenorphine would require an in-person visit after 6 months, but other psychiatric medications may not have that requirement if you have the special registration.

Can psychiatric nurse practitioners prescribe stimulants via telehealth?

It depends on the state. In Texas, NPs cannot prescribe Schedule II controlled substances (including stimulants) for outpatient care at all. In California, New York, and Illinois, experienced NPs with appropriate authority can prescribe stimulants via telehealth just like psychiatrists (subject to federal and state rules).

What’s the difference between treating a new patient vs. an established patient via telehealth?

If a patient has been seen in person by you or another provider in your practice at any point, there are no federal restrictions on prescribing controlled substances via telehealth for ongoing care. For brand-new patients who have never been seen in person by anyone, current federal rules allow telehealth prescribing through 2026, but permanent rules may require the special telemedicine registration.

Do I need a separate DEA registration for telehealth prescribing?

Not yet. The proposed special telemedicine registration is not currently in effect. Right now, you just need your regular DEA registration in each state where you practice. Once the permanent rules are finalized, psychiatrists who want to prescribe Schedule II meds via telehealth indefinitely will need to obtain the special registration.

Can I do telephone-only visits and prescribe controlled substances?

Generally no, except for buprenorphine for opioid use disorder. For other controlled substances (stimulants, benzodiazepines), the DEA expects interactive video. Audio-only doesn’t meet the standard for establishing a legitimate telemedicine relationship under the Ryan Haight Act.

What PDMP requirements do I need to follow?

This varies by state. California requires checking CURES before the first controlled substance prescription and every 4 months thereafter. New York requires checking the PMP every time you prescribe Schedule II–IV controlled substances. Texas requires checks before prescribing opioids, benzos, barbiturates, or carisoprodol. Check your state’s specific requirements.

Can I prescribe controlled substances to patients in other states?

Only if you’re licensed in those states and have a DEA registration in each state. You must follow the telehealth and prescribing rules of the state where the patient is located. Some states offer special telehealth registrations (like Florida) that may help with this.

What happens if I prescribe controlled substances via telehealth and don’t follow the rules?

You could face disciplinary action from your state medical or nursing board, DEA sanctions (including loss of DEA registration), and potentially criminal liability if you’re found to be prescribing outside the scope of legitimate medical practice. Always document thoroughly and follow both federal and state requirements.

Sources

1. U.S. Department of Health and Human Services, ‘HHS & DEA Extend Telemedicine Flexibilities for Prescribing Controlled Medications Through 2026,’ Press Release, January 2, 2026. https://www.hhs.gov/press-room/dea-telemedicine-extension-2026.html

2. U.S. Drug Enforcement Administration, ‘DEA Announces Three New Telemedicine Rules to Continue Open Access to Vital Care,’ Press Release, January 16, 2025. https://www.dea.gov/press-releases/2025/01/16/dea-announces-three-new-telemedicine-rules-continue-open-access

3. Florida Statutes §456.47, ‘Use of telehealth to provide services,’ 2025 Edition. http://www.leg.state.fl.us/statutes/index.cfm?Appmode=DisplayStatute&URL=0400-0499/0456/Sections/0456.47.html

4. Akerman LLP, ‘Harmonizing Federal and Florida Laws on Prescribing Controlled Substances Through Telehealth,’ Healthcare Bulletin, March 2023. https://www.akerman.com/en/perspectives/hrx-harmonizing-federal-and-florida-laws-on-prescribing-controlled-substances-through-telehealth.html

5. Tebra (The Intake), ‘State-by-State Breakdown of Nurse Practitioner Practice Authority Laws,’ Updated December 4, 2025. https://www.tebra.com/theintake/checklists-and-guides/legal-and-compliance/nurse-practitioner-laws-by-state

Source:

• https://www.hhs.gov/press-room/dea-telemedicine-extension-2026.html#:~:text=WASHINGTON%E2%80%94JANUARY%202%2C%202026%E2%80%94The%20U,while%20permanent%20rules%20are%20finalized
• https://www.hhs.gov/press-room/dea-telemedicine-extension-2026.html#:~:text=announced%20a%20fourth%20temporary%20extension,while%20permanent%20rules%20are%20finalized
• https://www.dea.gov/press-releases/2025/01/16/dea-announces-three-new-telemedicine-rules-continue-open-access#:~:text=Expansion%20of%20Buprenorphine%20Treatment%20via,Telemedicine%20Encounter
• https://www.dea.gov/press-releases/2025/01/16/dea-announces-three-new-telemedicine-rules-continue-open-access#:~:text=registration%20is%20available%20to%20medical,V%20medications
• https://www.dea.gov/press-releases/2025/01/16/dea-announces-three-new-telemedicine-rules-continue-open-access#:~:text=For%20the%20first%20time%20online,being%20of%20patients
• https://www.dea.gov/press-releases/2025/01/16/dea-announces-three-new-telemedicine-rules-continue-open-access#:~:text=In%20developing%20these%20rules%2C%20DEA,person%20by%20the%20medical%20provider
• https://www.akerman.com/en/perspectives/hrx-harmonizing-federal-and-florida-laws-on-prescribing-controlled-substances-through-telehealth.html#:~:text=telehealth%20to%20prescribe%20schedules%20III,one%20of%20the%20following%20categories
• https://www.jdsupra.com/legalnews/states-and-feds-signal-big-changes-to-9301791/#:~:text=of%20Ohio%E2%80%99s%20new%20telehealth%20prescribing,substance%20use%20disorder%20treatment%2C%20is
• https://www.akerman.com/en/perspectives/hrx-harmonizing-federal-and-florida-laws-on-prescribing-controlled-substances-through-telehealth.html#:~:text=No%20special%20registration%20is%20required,the%20State%20to%20do%20so
• https://www.tebra.com/theintake/checklists-and-guides/legal-and-compliance/nurse-practitioner-laws-by-state#:~:text=,start%20their%20own%20medical%20practices